By Wendell Oliver Espanola, MD

This is an annual meeting that began in 1998 which alternates yearly between Singapore and Malaysia with this year’s theme “Rheumatology in the 21st Century”.

Gabay sa pagbakuna laban sa COVID-19 ng mga pasyente na may autoimmune inflammatory disease.

Webinars and remote learning have existed for more than ten years. However, the pandemic has suddenly catapulted us into the virtual dimension, now a rapidly evolving and challenging landscape – what to do, and how?

As cheesy as that quote may be, truth is, the success of this year’s lupus roadshow would not have been possible if not for all the great minds coming together and realizing the dream to hold a lecture series of this magnitude during a worldwide pandemic.

In what has been an exciting and informative first-of-its-kindlupus roadshow, this year’s supposed series of lectures turned intoa weekly webinar series spanning almost 3 months.

Pulling off the 5th series of the Lupus Roadshow webinar is a story of a lupus patient who went thru a steep ride to survival. Attended by 155 participants, we were indulged with practical lessons that are timely and applicable both to lupus and non-lupus patients.

After we’ve been indulged by a case of pregnant lupus with renal flare in 14 November roadshow webinar, this next chapter challenged us with yet another
rollercoaster ride of events from a patient

Lupus nephritis is one, if not the most dreaded complication of SLE. Rheumatologists are always on the lookout for signs or symptoms hinting that their patient is developing nephritis.

Forging alliances, a theme substantiated by the second series of the Lupus Roadshow webinar held last 17 October 2020, 1-3 PM. It was another fruitful Saturday afternoon when a multidisciplinary case was presented

The University of Santo Tomas Hospital (USTH) and St. Luke’s Medical Center – Quezon City (SLMC-QC) Sections of Rheumatology, in partnership with Lupus Academy, Lupus Inspired Advocacy (LUISA) of Rheumatology Educational Trust Foundation, Inc. (RETFI), and Philippine Rheumatology Association (PRA)